Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Airbag for people: new wearable tech aims to soften falls

NCT ID NCT05076565

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a smart wearable airbag that detects when someone is falling and inflates to cushion the impact. It is designed for people at high risk of falling, such as those with stroke, Parkinson's disease, or a leg amputation. The goal is to see if the device can reduce fall-related injuries. About 200 participants will be enrolled to evaluate how well the system works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2018

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION AND EXCLUSION CRITERIA All potential subjects will be evaluated by research staff in order to match them to the inclusion and exclusion criteria that has been established - see below: Inclusion Criteria - Able bodied Subjects: * Healthy, able-bodied subject * Age constrained from 18-70 years old * No injury to either upper or lower extremity or history of back pain * English speaking. Exlusion Criteria - Able bodied Subjects: * Waist circumference greater than 125 cm * Pregnant women (status determined by self-reporting) * Co-morbidity that interferes with the study (e.g. significant arthritis or joint problems, history of back injury, neuromuscular disorders, stroke, epilepsy, etc.) * Individuals currently on anti-coagulants. * Inactive, physically unfit * Severe Osteoporosis (status determined by self-reporting) * Non-English speaking * Cognitive deficits or visual impairments (MMSE score \<17) that would impair their ability to give informed consent or impair their ability to follow simple instructions during the experiments Inclusion Criteria - Fall Risk Subjects: * Ages between 18-85 years old * Individuals diagnosed with a Stroke (\> 6 months post), Parkinson's disease, aging elderly (ages 60-85)or lower-limb amputee with at least one self-reported fall in the last six months. * Able to sit unsupported, walk at least with an assistive device and be able to follow a three-step command. * For individuals with Parkinson's disease, Scoring 1 or higher on questions in Section II (Activities of Daily Living) and Section III (Motor examinations) on the Unified PD Rating Scale (UPDRS), be able to walk at least with an assistive device and be able to follow a three-step command. * Waist circumference between 90 and 125 cm * Either homebound or community ambulators. * Willing to carry and use a smartphone and Airbag device. * Willing to wear the airbag system as directed by the research personnel. * English speaking * Able and willing to give written consent and comply with study procedures. Exclusion Criteria - Fall Risk Subjects * Serious cardiac conditions, any musculoskeletal disorder, or other comorbidities that would interfere with participation in this minimal risk study. * Non-healing ulcers of a lower extremity, Renal dialysis or end-stage liver disease, Legal blindness or severe visual impairment, a history of significant psychiatric illness. * Subjects reporting a head injury from exposure to a blast/concussion injury with one or more of the following symptoms: dizziness, vertigo, headache, migraine, oscillopsia, movement induced vertigo, imbalance. * Individuals who use a wheelchair for mobility both outdoors and indoors. * Waist circumference greater than 125 cm * Non-English speaking individuals * Severe Osteoporosis (status determined by self-reporting,medical records) * The subject is pregnant, nursing or planning a pregnancy. * Individuals currently on anti-coagulants. * Cognitive deficits or visual impairments (MMSE score \< 17) that would impair their ability to give informed consent or impair their ability to follow simple instructions during the experiments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fall injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.